Enhanced skin permeation using polyarginine modified nanostructured lipid carriers

Journal of Controlled Release

Volumn 161, Issue 3, 2012, Pages 735-745

  P Shah, Punit ^a   R Desai, Pinaki ^a   Channer, Debra ^a   Singh, Mandip ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Allergic contact dermatitis (ACD); Cell penetrating peptide (CPP); Nanostructured lipid carriers (NLC); Polyarginine peptide; Skin delivery

Indexed keywords

CELL-PENETRATING PEPTIDE; CONTACT DERMATITIS; NANOSTRUCTURED LIPID CARRIERS; POLYARGININE; SKIN DELIVERY;

ARGININE; CONFOCAL MICROSCOPY; DESIGN OF EXPERIMENTS; DRUG PRODUCTS; ENCAPSULATION; MAMMALS;

PEPTIDES;

CELL PENETRATING PEPTIDE; KETOPROFEN; NANOMATERIAL; NANOSTRUCTURED LIPID CARRIER; POLYARGININE; SPANTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; INFLAMMATION; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAMAN SPECTROMETRY; RAT; SKIN ALLERGY; SKIN PERMEABILITY;

ADMINISTRATION, TOPICAL; ALLERGENS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL-PENETRATING PEPTIDES; DERMATITIS, ALLERGIC CONTACT; DINITROFLUOROBENZENE; DRUG CARRIERS; KETOPROFEN; LIPIDS; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; OLIGOPEPTIDES; PEPTIDES; RATS; RATS, HAIRLESS; SKIN ABSORPTION; SUBSTANCE P;

EID: 84864613798     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.05.011     Document Type: Article

References (55)

1. L.B. Jensen, K. Petersson, and H.M. Nielsen In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin Eur. J. Pharm. Biopharm. 79 2011 68 75
2. H. Inoue, N. Nagata, and Y. Koshihara Involvement of substance P as a mediator in capsaicin-induced mouse ear oedema Inflamm. Res. 44 1995 470 474
3. R.J. Babu, L. Kikwai, L. Jaiani, N. Kanikkannan, C. Armstrong, J. Ansel, and M. Singh Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II Pharm. Res. 21 2004 108 113 (Pubitemid 38122298)
4. L. Kikwai, R.J. Babu, R. Prado, A. Kolot, C.A. Armstrong, J.C. Ansel, and M. Singh In vitro and in vivo evaluation of topical formulations of spantide II AAPS PharmSciTech 6 2005 E565 E572
5. N. Shinkai, K. Korenaga, Y. Okumura, H. Mizu, and H. Yamauchi Microdialysis assessment of percutaneous penetration of ketoprofen after transdermal administration to hairless rats and domestic pigs Eur. J. Pharm. Biopharm. 78 2011 415 421
6. K. Atarashi, K. Kabashima, K. Akiyama, and Y. Tokura Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice Br. J. Dermatol. 159 2008 306 313 (Pubitemid 352009868)
7. L. Kikwai, R.J. Babu, N. Kanikkannan, and M. Singh Preformulation stability of Spantide II, a promising topical anti-inflammatory agent for the treatment of psoriasis and contact dermatitis J. Pharm. Pharmacol. 56 2004 19 25 (Pubitemid 38195324)
8. M.M. Abdel-Mottaleb, D. Neumann, and A. Lamprecht Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers Eur. J. Pharm. Biopharm. 79 2011 36 42
9. P. Karande, A. Jain, and S. Mitragotri Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery J. Control. Release 115 2006 85 93 (Pubitemid 44415077)
10. B. Barry Mode of action of penetration enhancers in human skin J. Control. Release 6 1987 85 97 (Pubitemid 18017724)
11. B. Polat, D. Hart, R. Langer, and D. Blankschtein Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends J. Control. Release 152 2011 330 348
12. A. Sintov, I. Krymberk, D. Daniel, T. Hannan, Z. Sohn, and G. Levin Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs J. Control. Release 89 2003 311 320 (Pubitemid 36507024)
13. Y. Henchoz, N. Abla, J. Veuthey, and P. Carrupt A fast screening strategy for characterizing peptide delivery by transdermal iontophoresis J. Control. Release 137 2009 123 129
14. H. Chen, H. Zhu, J. Zheng, D. Mou, J. Wan, J. Zhang, T. Shi, Y. Zhao, H. Xu, and X. Yang Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin J. Control. Release 139 2009 63 72
15. S. Murthy, S. Sammeta, and C. Bowers Magnetophoresis for enhancing transdermal drug delivery: mechanistic studies and patch design J. Control. Release 148 2010 197 203
16. R. Vanbever, G. Langers, S. Montmayeur, and V. Préat Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation J. Control. Release 50 1998 225 235 (Pubitemid 28044117)
17. S. Bal, A. Kruithof, R. Zwier, E. Dietz, J. Bouwstra, J. Lademann, and M. Meinke Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo J. Control. Release 147 2010 218 224
18. G. Cevc, and U. Vierl Nanotechnology and the transdermal route: a state of the art review and critical appraisal J. Control. Release 141 2010 277 299
19. P. Desai, R.R. Patlolla, and M. Singh Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery Mol. Membr. Biol. 27 2010 247 259
20. K. Mitri, R. Shegokar, S. Gohla, C. Anselmi, and R.H. Muller Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance Int. J. Pharm. 414 2011 267 275
21. M. Schafer-Korting, W. Mehnert, and H.C. Korting Lipid nanoparticles for improved topical application of drugs for skin diseases Adv. Drug Deliv. Rev. 59 2007 427 443 (Pubitemid 47259224)
22. P.V. Pople, and K.K. Singh Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis Int. J. Pharm. 398 2010 165 178
23. V. Teeranachaideekul, P. Boonme, E. Souto, R. Müller, and V. Junyaprasert Influence of oil content on physicochemical properties and skin distribution of nile red-loaded NLC J. Control. Release 128 2008 134 141
24. R.R. Patlolla, P.R. Desai, K. Belay, and M.S. Singh Translocation of cell penetrating peptide engrafted nanoparticles across skin layers Biomaterials 31 2010 5598 5607
25. S.B. Fonseca, M.P. Pereira, and S.O. Kelley Recent advances in the use of cell-penetrating peptides for medical and biological applications Adv. Drug Deliv. Rev. 61 2009 953 964
26. K. Kigasawa, K. Kajimoto, T. Nakamura, S. Hama, K. Kanamura, H. Harashima, and K. Kogure Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy J. Control. Release 150 2011 256 265
27. M. Cohen-Avrahami, A. Aserin, and N. Garti H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac Colloids Surf. B Biointerfaces 77 2010 131 138
28. M. Cohen-Avrahami, D. Libster, A. Aserin, and N. Garti Sodium diclofenac and cell-penetrating peptides embedded in H(II) mesophases: physical characterization and delivery J. Phys. Chem. B 115 2011 10189 10197
29. S. Futaki Membrane-permeable arginine-rich peptides and the translocation mechanisms Adv. Drug Deliv. Rev. 57 2005 547 558 (Pubitemid 40255560)
30. A. Jones, and E. Sayers Cell entry of cell penetrating peptides: tales of tails wagging dogs J. Control. Release 161 2012 582 591
31. N. Mennini, S. Furlanetto, M. Cirri, and P. Mura Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex Eur. J. Pharm. Biopharm. 80 2012 67 75
32. P.P. Shah, and R.C. Mashru Influence of chitosan crosslinking on bitterness of mefloquine hydrochloride microparticles using central composite design J. Pharm. Sci. 98 2009 690 703
33. P.P. Shah, R.C. Mashru, Y.M. Rane, and A.C. Badhan Design and optimization of artemether microparticles for bitter taste masking Acta Pharm. 58 2008 379 392
34. R. Babu, N. Kanikkannan, L. Kikwai, C. Ortega, S. Andega, K. Ball, S. Yim, and M. Singh The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide J. Control. Release 86 2003 49 57 (Pubitemid 35461973)
35. N. Ghouchi Eskandar, S. Simovic, and C.A. Prestidge Nanoparticle coated submicron emulsions: sustained in-vitro release and improved dermal delivery of all-trans-retinol Pharm. Res. 26 2009 1764 1775
36. P.P. Shah, P.R. Desai, A. Patel, and M. Singh Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs Biomaterials 33 2012 1607 1617
37. P.P. Shah, P.R. Desai, and M. Singh Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen J. Control. Release 158 2011 336 345
38. M. Chougule, A.R. Patel, P. Sachdeva, T. Jackson, and M. Singh Anticancer activity of noscapine, an opioid alkaloid in combination with cisplatin in human non-small cell lung cancer Lung Cancer 71 2012 271 282
39. A.C. Badhan, R.C. Mashru, P.P. Shah, A.R. Thakkar, and N.B. Dobaria Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection AAPS PharmSciTech 10 2009 459 467
40. E.B. Souto, and R. Müller Cosmetic features and applications of lipid nanoparticles (SLN, NLC) Int. J. Cosmet. Sci. 30 2008 157 165 (Pubitemid 351623837)
41. W.C. Mak, H. Richter, A. Patzelt, W. Sterry, K.K. Lai, R. Renneberg, and J. Ladermann Drug delivery into the skin by degradable particles Eur. J. Pharm. Biopharm. 79 2011 23 27
42. T. Uchida, T. Kanazawa, Y. Takashima, and H. Okada Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002 Chem. Pharm. Bull.(Tokyo) 59 2011 196 201
43. M. Cohen-Avrahami, D. Libster, A. Aserin, and N. Garti Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac J. Control. Release 159 2012 419 428
44. T. Hsu, and S. Mitragotri Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer Proc. Natl. Acad. Sci. U.S.A. 108 2011 15816 15821
45. F. Knorr, J. Lademann, A. Patzelt, W. Sterry, U. Blume-Peytavi, and A. Vogt Follicular transport route - research progress and future perspectives Eur. J. Pharm. Biopharm. 71 2009 173 180
46. D.J. Mitchell, D.T. Kim, L. Steinman, C.G. Fathman, and J.B. Rothbard Polyarginine enters cells more efficiently than other polycationic homopolymers J. Pept. Res. 56 2000 318 325
47. P. Dayal, V. Pillay, R.J. Babu, and M. Singh Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension AAPS PharmSciTech 6 2005 E573 E585
48. P.P. Shah, R.C. Mashru, A.R. Thakkar, and A.C. Badhan Effect of chitosan crosslinking on bitterness of artemether using response surface methodology J. Pharm. Pharmacol. 60 2008 421 427 (Pubitemid 351500552)
49. Y.M. Rane, R.C. Mashru, M.G. Sankalia, V.B. Sutariya, and P.P. Shah Investigations on factors affecting chitosan for dissolution enhancement of oxcarbazepine by spray dried microcrystal formulation with an experimental design approach Drug Dev. Ind. Pharm. 33 2007 1008 1023 (Pubitemid 47463808)
50. P.P. Shah, R.C. Mashru, Y.M. Rane, and A. Thakkar Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking AAPS PharmSciTech 9 2008 377 389
51. L. Kikwai, R.J. Babu, N. Kanikkannan, and M. Singh Stability and degradation profiles of spantide II in aqueous solutions Eur. J. Pharm. Sci. 27 2006 158 166 (Pubitemid 41831251)
52. J. Hamdani, A.J. Moës, and K. Amighi Physical and thermal characterisation of precirol and compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets Int. J. Pharm. 260 2003 47 57 (Pubitemid 36724860)
53. H. Yamashita, T. Ito, H. Kato, S. Asai, H. Tanaka, H. Nagai, and N. Inagaki Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis Eur. J. Pharmacol. 645 2010 171 176
54. Y.V. Saripalli, J.E. Gadzia, and D. Belsito Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis J. Am. Acad. Dermatol. 49 2003 477 482 (Pubitemid 37051911)
55. D. Belsito, D.C. Wilson, E. Warshaw, J. Fowler, A. Ehrlich, B. Anderson, B.E. Strober, J. Willetts, and E.S. Rutledge A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis J. Am. Acad. Dermatol. 55 2006 40 46 (Pubitemid 43867046)